Literature DB >> 19882153

Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.

Koon-Pong Wong1, Mirwais Wardak, Weber Shao, Magnus Dahlbom, Vladimir Kepe, Jie Liu, Nagichettiar Satyamurthy, Gary W Small, Jorge R Barrio, Sung-Cheng Huang.   

Abstract

PURPOSE: Subcortical white matter is known to be relatively unaffected by amyloid deposition in Alzheimer's disease (AD). We investigated the use of subcortical white matter as a reference region to quantify [(18)F]FDDNP binding in the human brain.
METHODS: Dynamic [(18)F]FDDNP PET studies were performed on 7 control subjects and 12 AD patients. Population efflux rate constants (k(')(2)) from subcortical white matter (centrum semiovale) and cerebellar cortex were derived by a simplified reference tissue modeling approach incorporating physiological constraints. Regional distribution volume ratio (DVR) estimates were derived using Logan and simplified reference tissue approaches, with either subcortical white matter or cerebellum as reference input. Discriminant analysis with cross-validation was performed to classify control subjects and AD patients.
RESULTS: The population estimates of k(')(2) in subcortical white matter did not differ significantly between control subjects and AD patients but the variability of individual estimates of k(')(2) determined in white matter was lower than that in cerebellum. Logan DVR showed dependence on the efflux rate constant in white matter. The DVR estimates in the frontal, parietal, posterior cingulate, and temporal cortices were significantly higher in the AD group (p<0.01). Incorporating all these regional DVR estimates as predictor variables in discriminant analysis yielded accurate classification of control subjects and AD patients with high sensitivity and specificity, and the results agreed well with those using the cerebellum as the reference region.
CONCLUSION: Subcortical white matter can be used as a reference region for quantitative analysis of [(18)F]FDDNP with the Logan method which allows more accurate and less biased binding estimates, but a population efflux rate constant has to be determined a priori.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19882153      PMCID: PMC2822232          DOI: 10.1007/s00259-009-1293-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  25 in total

1.  Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Authors:  Brian J Lopresti; William E Klunk; Chester A Mathis; Jessica A Hoge; Scott K Ziolko; Xueling Lu; Carolyn C Meltzer; Kurt Schimmel; Nicholas D Tsopelas; Steven T DeKosky; Julie C Price
Journal:  J Nucl Med       Date:  2005-12       Impact factor: 10.057

2.  Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Authors:  Jonghan Shin; Sang-Yoon Lee; So-Hee Kim; Young-Bo Kim; Seong-Jin Cho
Journal:  Neuroimage       Date:  2008-07-23       Impact factor: 6.556

3.  Simplified parametric methods for [18F]FDDNP studies.

Authors:  Maqsood Yaqub; Nelleke Tolboom; Bart N M van Berckel; Philip Scheltens; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Neuroimage       Date:  2009-07-28       Impact factor: 6.556

4.  Simplified reference tissue model for PET receptor studies.

Authors:  A A Lammertsma; S P Hume
Journal:  Neuroimage       Date:  1996-12       Impact factor: 6.556

5.  Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Nakazato
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Neuroreceptor assay with positron emission tomography: equilibrium versus dynamic approaches.

Authors:  S C Huang; J R Barrio; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1986-10       Impact factor: 6.200

7.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

8.  Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies.

Authors:  C L Masters; D C Gajdusek; C J Gibbs
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

9.  Comparison of methods for analysis of clinical [11C]raclopride studies.

Authors:  A A Lammertsma; C J Bench; S P Hume; S Osman; K Gunn; D J Brooks; R S Frackowiak
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

10.  Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Authors:  Christopher C Rowe; Uwe Ackerman; William Browne; Rachel Mulligan; Kerryn L Pike; Graeme O'Keefe; Henry Tochon-Danguy; Gordon Chan; Salvatore U Berlangieri; Gareth Jones; Kerryn L Dickinson-Rowe; Hank P Kung; Wei Zhang; Mei Ping Kung; Daniel Skovronsky; Thomas Dyrks; Gerhard Holl; Sabine Krause; Matthias Friebe; Lutz Lehman; Stefanie Lindemann; Ludger M Dinkelborg; Colin L Masters; Victor L Villemagne
Journal:  Lancet Neurol       Date:  2008-01-10       Impact factor: 44.182

View more
  16 in total

1.  Prediction of cognitive decline based on hemispheric cortical surface maps of FDDNP PET.

Authors:  Hillary D Protas; Vladimir Kepe; Kiralee M Hayashi; Andrea D Klunder; Meredith N Braskie; Linda Ercoli; Prabha Siddarth; Susan Y Bookheimer; Paul M Thompson; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  Neuroimage       Date:  2012-02-28       Impact factor: 6.556

2.  Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation.

Authors:  John M Ringman; Karen H Gylys; Luis D Medina; Michelle Fox; Vladimir Kepe; Deborah L Flores; Liana G Apostolova; Jorge R Barrio; Gary Small; Daniel H Silverman; Erin Siu; Stephen Cederbaum; Silva Hecimovic; Martina Malnar; Suma Chakraverty; Alison M Goate; Thomas D Bird; James B Leverenz
Journal:  Neurosci Lett       Date:  2010-11-19       Impact factor: 3.046

3.  Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue model.

Authors:  Matts Kågedal; Katarina Varnäs; Andrew C Hooker; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

4.  Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Authors:  Michel Koole; June van Aalst; Martijn Devrome; Nathalie Mertens; Kim Serdons; Brigitte Lacroix; Joel Mercier; David Sciberras; Paul Maguire; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-18       Impact factor: 9.236

5.  Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.

Authors:  Sepideh Shokouhi; Desmond Campbell; Aaron B Brill; Harry E Gwirtsman
Journal:  Brain Pathol       Date:  2016-09       Impact factor: 6.508

6.  Effect of Region of Interest Size on the Repeatability of Quantitative Brain Imaging Biomarkers.

Authors:  Kourosh Jafari-Khouzani; Kamran Paynabar; Fatemeh Hajighasemi; Bruce Rosen
Journal:  IEEE Trans Biomed Eng       Date:  2018-07-27       Impact factor: 4.538

7.  Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.

Authors:  Koon-Pong Wong; Vladimir Kepe; Magnus Dahlbom; Nagichettiar Satyamurthy; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  Neuroimage       Date:  2011-12-16       Impact factor: 6.556

8.  Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humans.

Authors:  Jenna M Sullivan; Keunpoong Lim; David Labaree; Shu-Fei Lin; Timothy J McCarthy; John P Seibyl; Gilles Tamagnan; Yiyun Huang; Richard E Carson; Yu-Shin Ding; Evan D Morris
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-19       Impact factor: 6.200

9.  Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.

Authors:  Mirwais Wardak; Koon-Pong Wong; Weber Shao; Magnus Dahlbom; Vladimir Kepe; Nagichettiar Satyamurthy; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  J Nucl Med       Date:  2010-01-15       Impact factor: 10.057

10.  FDDNP binding using MR derived cortical surface maps.

Authors:  H D Protas; S-C Huang; V Kepe; K Hayashi; A Klunder; M N Braskie; L Ercoli; S Bookheimer; P M Thompson; G W Small; J R Barrio
Journal:  Neuroimage       Date:  2009-08-22       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.